ESSA Pharma Inc is a pharmaceutical company. The company is in the preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen recepto... ESSA Pharma Inc is a pharmaceutical company. The company is in the preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. 더 보기
March 25, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against EPIX PR Newswire NEW YORK, Feb. 3, 2025 NEW YORK, Feb. 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the...
Shareholders of ESSA Pharma Inc. Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights - EPIX PR Newswire NEW YORK, Jan. 30, 2025 NEW YORK, Jan. 30, 2025 /PRNewswire/...
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024 PR Newswire SOUTH SAN FRANCISCO, California and VANCOUVER, Canada...
ESSA Pharma Announces Termination of Phase 2 Study Evaluating Masofaniten Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer PR Newswire SOUTH SAN...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.12 | -6.66666666667 | 1.8 | 1.81 | 1.67 | 181153 | 1.71469357 | CS |
4 | -0.27 | -13.8461538462 | 1.95 | 1.95 | 1.67 | 164258 | 1.75526926 | CS |
12 | -0.11 | -6.14525139665 | 1.79 | 1.95 | 1.57 | 343172 | 1.75162904 | CS |
26 | -3.04 | -64.406779661 | 4.72 | 7.88 | 1.4 | 546692 | 1.78761463 | CS |
52 | -7.57 | -81.8378378378 | 9.25 | 11.67 | 1.4 | 316027 | 2.62303242 | CS |
156 | -7.76 | -82.2033898305 | 9.44 | 11.67 | 1.4 | 495326 | 4.02016126 | CS |
260 | -3.85 | -69.6202531646 | 5.53 | 36 | 1.4 | 387536 | 6.84689378 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관